Category: Latest News
-
Markets Rebound: S&P 500 Climbs on Renewed Hopes for Fed Rate Cuts, Tech Stocks Lead
U.S. equities advanced sharply on Monday, reversing steep losses from Friday as investor confidence grew around the prospect of an earlier interest rate cut from the Federal Reserve. Gains in major technology firms, buoyed by strong earnings, helped fuel the rally. By the close of trading at 4:00 p.m. ET, the Dow Jones Industrial Average…
-
U.S. Stocks Rally On Bargain Hunting, Interest Rate Cut Optimism
Stocks moved sharply higher early in the session on Monday and continued to turn in a strong performance throughout the day. With the upward move, the major averages offset a large chunk of the notable pullback seen over the two previous sessions. The major averages saw further upside going into the close, ending the day…
-
Spotify shares jump after announcing planned Premium subscription price hikes
Spotify Technology SA (NYSE:SPOT) saw its stock climb 5.4% following news that the company intends to increase prices for its Premium subscription service in several international markets. The streaming leader outlined plans to raise Premium subscription fees within the next month across regions such as South Asia, the Middle East, Africa, Europe, Latin America, and…
-
American Eagle shares jump after Trump’s social media shoutout
American Eagle Outfitters (NYSE:AEO) saw its stock surge up to 14% early Monday following a mention by former President Donald Trump on his social media platform, Truth Social. Trump highlighted actress Sydney Sweeney’s recent American Eagle commercial, praising it by saying the jeans she’s modeling are “flying off the shelves.” His remarks sparked a strong…
-
Boeing Faces Strike as Union Rejects Contract Offer, Shares Dip
Boeing (NYSE:BA) was hit by a strike Monday as approximately 3,200 machinists from IAM District 837 began walkouts after rejecting the company’s second contract proposal. According to Jefferies, the strike—which started at midnight CT on August 4—impacts about 2% of Boeing’s total workforce. The affected employees manufacture fighter jets, including the F-15 and F/A-18, as…
-
TransMedics Stock Surges Following FDA Conditional Approval for Heart Trial
TransMedics Group Inc (NASDAQ:TMDX) stock jumped 6.7% after the company announced that the U.S. Food and Drug Administration (FDA) granted conditional approval for its Investigational Device Exemption (IDE), allowing the Next-Generation OCS ENHANCE Heart trial to proceed. The ENHANCE trial will be conducted in two phases: Part A will focus on supporting prolonged heart perfusion…
-
DoorDash Stock Hits 52-Week High of $252.94
DoorDash Inc (NASDAQ:DASH) stock soared to a new 52-week high of $252.94, underscoring investor confidence in the company’s strong growth trajectory. Over the past year, the stock has more than doubled, gaining an impressive 108.07%, reflecting robust market sentiment and faith in DoorDash’s evolving business model. The company currently holds a market capitalization of $105.24…
-
Dollar Tree Stock Hits 52-Week High of $116.14
Dollar Tree Inc (NASDAQ:DLTR) stock surged to a 52-week high of $116.14, marking a key milestone for the discount retailer. The company now boasts a market capitalization of $24.14 billion and a price-to-earnings ratio of 22.51, reflecting strong investor confidence. Over the past six months, Dollar Tree’s shares have gained more than 54%, contributing to…
-
Inspire Veterinary Partners Stock Declines 2% Following $10 Million Convertible Offering
Shares of Inspire Veterinary Partners Inc (NASDAQ:IVP) dropped 2% after the pet healthcare services provider announced a new convertible preferred stock offering valued at up to $10 million. The company disclosed that the securities purchase agreement includes a mix of cash and transferred securities priced at $1.00 per share. The initial closing is expected to…
-
CASI Pharmaceuticals Stock Surges 12.4% Following FDA Clearance for Transplant Drug
CASI Pharmaceuticals Inc (NASDAQ:CASI) shares jumped 12.4% after the clinical-stage biopharmaceutical company announced the U.S. Food and Drug Administration (FDA) granted clearance for an Investigational New Drug (IND) application for CID-103, its anti-CD38 monoclonal antibody therapy. The FDA approval enables CASI to initiate a Phase 1 clinical trial to evaluate CID-103 in adult patients suffering…